LUXHT
Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingEqual
- # of holdings43
What's inside?
Holdings
All holdings as of January 10, 2025
| Guardant Health, Inc. (GH) | 3.60% | $4.54B | 33.87% | 61.10% | 4.57 |
| iRhythm Technologies, Inc. (IRTC) | 3.39% | $3.06B | 18.41% | 68.78% | 4.53 |
| Hims & Hers Health, Inc. (HIMS) | 3.13% | $5.55B | 77.13% | 67.33% | 3.29 |
| Waystar Holding Corp. (WAY) | 3.02% | $6.45B | 21.72% | 41.39% | 6.66 |
| GRAIL, Inc. (GRAL) | 2.97% | $595.74M | 38.27% | -77.60% | -2.76 |
| Natera, Inc. (NTRA) | 2.94% | $23.10B | 63.90% | 61.79% | 9.97 |
| Cytek Biosciences, Inc. (CTKB) | 2.94% | $878.49M | 7.29% | 56.32% | 2.44 |
| Veracyte, Inc. (VCYT) | 2.76% | $3.22B | 28.58% | 66.19% | 5.68 |
| Globus Medical, Inc. (GMED) | 2.69% | $11.86B | 63.10% | 51.96% | 3.92 |
| Pacific Biosciences of California, Inc. (PACB) | 2.68% | $575.11M | -28.23% | 7.39% | 5.27 |
| Masimo Corp. (MASI) | 2.61% | $8.91B | 5.37% | 52.16% | 3.88 |
| PROCEPT BioRobotics Corp. (PRCT) | 2.60% | $4.72B | 66.29% | 60.96% | 20.27 |
| Doximity, Inc. (DOCS) | 2.59% | $9.73B | 20.44% | 90.01% | 15.36 |
| Adaptive Biotechnologies Corp. (ADPT) | 2.59% | $959.27M | 22.46% | 58.81% | 4.15 |
| Insulet Corp. (PODD) | 2.58% | $19.07B | 25.70% | 70.12% | 8.93 |
| Progyny, Inc. (PGNY) | 2.53% | $1.60B | 2.04% | 20.67% | 1.19 |
| DexCom, Inc. (DXCM) | 2.49% | $30.37B | 1.97% | 59.73% | 6.98 |
| Intuitive Surgical, Inc. (ISRG) | 2.48% | $195.00B | 16.88% | 67.41% | 22.12 |
| Lifestance Health Group, Inc. (LFST) | 2.44% | $2.96B | 18.95% | 27.28% | 2.53 |
| Schrödinger, Inc. (SDGR) | 2.41% | $1.40B | -17.10% | 50.24% | 5.55 |
| Teladoc Health, Inc. (TDOC) | 2.39% | $1.70B | -2.99% | 57.95% | 0.74 |
| Veeva Systems, Inc. (VEEV) | 2.32% | $35.35B | 13.41% | 75.06% | 11.09 |
| NeoGenomics, Inc. (NEO) | 2.31% | $1.90B | 10.44% | 42.56% | 3.25 |
| Castle Biosciences, Inc. (CSTL) | 2.26% | $847.22M | 39.50% | 78.57% | 1.88 |
| Twist Bioscience Corp. (TWST) | 2.20% | $2.60B | 27.69% | 42.61% | 7.76 |
| ResMed, Inc. (RMD) | 2.19% | $34.32B | 11.08% | 57.64% | 7.58 |
| Definitive Healthcare Corp. (DH) | 2.13% | $653.75M | -4.02% | 63.09% | 2.58 |
| Illumina, Inc. (ILMN) | 2.12% | $21.68B | -3.49% | 68.98% | 5.14 |
| Inspire Medical Systems, Inc. (INSP) | 2.07% | $6.07B | 32.54% | 84.06% | 8.05 |
| Clover Health Investments Corp. (CLOV) | 1.98% | $1.82B | -31.34% | N/A | 0.90 |
| Health Catalyst, Inc. (HCAT) | 1.96% | $419.24M | 3.50% | 31.77% | 1.55 |
| Hologic, Inc. (HOLX) | 1.95% | $16.27B | -0.00% | 55.52% | 4.84 |
| IQVIA Holdings, Inc. (IQV) | 1.94% | $36.89B | 4.06% | 28.18% | 3.63 |
| Fulgent Genetics, Inc. (FLGT) | 1.93% | $560.04M | -15.28% | 34.54% | 1.64 |
| Align Technology, Inc. (ALGN) | 1.92% | $15.84B | 1.84% | 70.10% | 4.57 |
| Tandem Diabetes Care, Inc. (TNDM) | 1.90% | $2.36B | 31.43% | 51.09% | 3.26 |
| EXACT Sciences Corp. (EXAS) | 1.82% | $10.46B | 12.78% | 68.88% | 5.33 |
| 10X Genomics, Inc. (TXG) | 1.72% | $1.89B | -1.30% | 69.50% | 3.83 |
| CareDx, Inc. (CDNA) | 1.69% | $1.27B | 23.35% | 65.97% | 4.61 |
| Tempus AI, Inc. (TEM) | 1.55% | $5.91B | 32.98% | 56.80% | 14.64 |
| Oscar Health, Inc. (OSCR) | 1.55% | $3.51B | 68.30% | N/A | 0.66 |
| GoodRx Holdings, Inc. (GDRX) | 1.42% | $1.73B | 8.50% | 85.04% | 3.56 |
| Myriad Genetics, Inc. (MYGN) | 1.25% | $1.35B | 11.15% | 65.31% | 3.08 |